Startup India Government of India
Rivinor Pharma Private Limited
Rivinor Pharma Private Limited - trading in Amravati, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹9.03 Lakh
▼ 45% YoY
Net loss · FY 2024
₹7.56 Lakh
Net margin -83.8%
EBITDA · FY 2024
-₹7.47 Lakh
EBITDA margin -82.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Rivinor Pharma Private Limited
Data last updated:
Rivinor Pharma Private Limited is a private limited company based in Amravati, Maharashtra, India, recognised as a startup by DPIIT. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 15 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U51900MH2019PTC321330. Its GSTIN is 27AAJCR4299N1ZG (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Vaishali Ujwal Barange and Vitthal Mahadeo Farkade.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 24 Wanrai Marg Prashant Nagar Rukhmini Nagar, Amravati, Maharashtra, India – 444606.
As per the financials filed for FY 2024, the company reported a revenue of ₹9.03 Lakh, a decline of 45% compared to the previous year. For the same year it recorded a net loss of ₹7.56 Lakh (net margin -83.8%) and EBITDA of -₹7.47 Lakh (EBITDA margin -82.7%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years.
Rivinor Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-03-0001512).
Company Details of Rivinor Pharma Private Limited
CIN U51900MH2019PTC321330
Registration Number 321330
Incorporation Date 15 February 2019
ROC Nagpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 25 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MH-03-0001512
Recognitions & Rankings of Rivinor Pharma
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-03-0001512
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address24 Wanrai Marg Prashant Nagar Rukhmini Nagar, Amravati, Maharashtra, India – 444606
- IndustryTrading, Specialty, Wholesale
Comprehensive company report
Rivinor Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Rivinor Pharma Private Limited
The main business activity of Rivinor Pharma is manufacturing. In detail, this covers manufacture of food products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 10 | Manufacture of food products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Rivinor Pharma Private Limited FY 2025 filings available
Rivinor Pharma Private Limited reported revenue of ₹9.03 Lakh (down 45% YoY) for FY 2024.
Revenue · FY 2024
₹9.03 Lakh ▼ 45%
Net loss · FY 2024
₹7.56 Lakh margin -83.8%
EBITDA · FY 2024
-₹7.47 Lakh margin -82.7%
Compounded Annual Growth Rate (CAGR) of Rivinor Pharma Private Limited
Revenue CAGR growth
1 year
▼ 45%
3 years · compounded
▼ 6%
EBITDA CAGR growth
3 years · compounded
▼ 232%
5 years · compounded
▼ 97%
Revenue has declined at a compounded annual rate (CAGR) of 6% over three years, including a 45% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Rivinor Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹7.47 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹7.56 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Rivinor Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -82.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -83.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Rivinor Pharma are in the company report.
Premium access
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Rivinor Pharma Private Limited
Rivinor Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vaishali Ujwal Barange | Director | 15 Feb 2019 | 7 Years 8 Months | Current |
| Vitthal Mahadeo Farkade | Director | 15 Feb 2019 | 7 Years 8 Months | Current |
Peer Comparison of Rivinor Pharma Private Limited
Rivinor Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Manufacture of food products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zmile Future Private Limited | ₹9.11 Lakh (FY 2025) | •••• | •••• | 24.0% | •••• | Nagpur, Maharashtra, India |
| Guria Marketing Private Limited | ₹9.11 Lakh (FY 2025) | •••• | •••• | -62.0% | •••• | Howrah, West Bengal, India |
| Tibsy Life Private Limited | ₹9.08 Lakh (FY 2024) | •••• | •••• | -40.0% | •••• | Gurugram, Haryana, India |
| GBH Industries Private Limited | ₹9.08 Lakh (FY 2024) | •••• | •••• | -23.0% | •••• | Bangalore, Karnataka, India |
| Sumala Agro Foods Private Limited | ₹9.05 Lakh (FY 2024) | •••• | •••• | -8.0% | •••• | Jalgaon, Maharashtra, India |
| Rivinor Pharma Private Limited this company | ₹9.03 Lakh (FY 2024) | •••• | •••• | -45.0% | •••• | Amravati, Maharashtra, India |
| Rastin Trading Private Limited | ₹9.01 Lakh (FY 2025) | •••• | •••• | •••• | Gurgaon, Haryana, India | |
| Pentacle Food Industries Private Limited | ₹8.98 Lakh (FY 2025) | •••• | •••• | -41.0% | •••• | Cuttack, Odisha, India |
| S.M.Graphotronic Private Limited | ₹8.89 Lakh (FY 2025) | •••• | •••• | -75.0% | •••• | New Delhi, Delhi, India |
| Yashodanandan Dairy Producer Company Limited | ₹8.83 Lakh (FY 2025) | •••• | •••• | 231.0% | •••• | Prayagraj, Uttar Pradesh, India |
| Ansheeka Food Processing Private Limited | ₹8.83 Lakh (FY 2025) | •••• | •••• | -64.0% | •••• | Raipur - Karchuliyan, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Rivinor Pharma by revenue in the same principal business activity (Manufacture of food products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Rivinor Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Rivinor Pharma Private Limited
Rivinor Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Rivinor Pharma Private Limited
Employment history and EPFO contributions of people linked to Rivinor Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Rivinor Pharma Private Limited
Rivinor Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Vaishali Ujwal Barange was appointed as Director on 15 Feb 2019.
AGM
Rivinor Pharma Private Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Filing
Rivinor Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Nagpur.
Appointed
Vaishali Ujwal Barange was appointed as Director.
Appointed
Vitthal Mahadeo Farkade was appointed as Director.
Incorporation
15 Feb 2019
Rivinor Pharma Private Limited was registered on 15 Feb 2019 with Roc Nagpur & aged 7 years 8 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Rivinor Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Rivinor Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rivinor Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Rivinor Pharma Private Limited
Rivinor Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCR4299N1ZG | Maharashtra | Active | 23 May 2019 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rivinor Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rivinor Pharma Private Limited
Rivinor Pharma is an active private limited company based in Amravati, Maharashtra, India. The company works in specialty, within the trading industry. It was incorporated on 15 February 2019 (7+ years old) and is registered under CIN U51900MH2019PTC321330.
Rivinor Pharma reported revenue of ₹9.03 Lakh for FY 2024 (down 45% YoY).
Rivinor Pharma has 2 current directors:
- Vaishali Ujwal Barange - Director
- Vitthal Mahadeo Farkade - Director
Rivinor Pharma reported a net loss of ₹7.56 Lakh (net margin -83.8%) and EBITDA of -₹7.47 Lakh (EBITDA margin -82.7%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Rivinor Pharma is -6% over three years. In the latest year (FY 2024) revenue fell 45%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Rivinor Pharma is 27AAJCR4299N1ZG, registered in Maharashtra.
The CIN (Corporate Identification Number) of Rivinor Pharma is U51900MH2019PTC321330. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rivinor Pharma was incorporated on 15 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Nagpur.
The peers of Rivinor Pharma by revenue are Zmile Future Private Limited, Guria Marketing Private Limited, Tibsy Life Private Limited, GBH Industries Private Limited, Sumala Agro Foods Private Limited and 5 more, all in the same principal business activity (Manufacture of food products).
Vaishali Ujwal Barange was appointed as Director on 15 Feb 2019. Vitthal Mahadeo Farkade was appointed as Director on 15 Feb 2019.
Yes, Rivinor Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).